Skip to main content
Clinical Trials/ACTRN12614000811606
ACTRN12614000811606
Completed
未知

A cluster-randomised controlled trial to evaluate the effect of a community-based lifestyle intervention on physical activity and dietary measures in Vietnamese adults aged 50-65 years with metabolic syndrome in a province in North Vietnam

WA Centre for Health Promotion Research, Curtin University0 sites417 target enrollmentJuly 31, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
WA Centre for Health Promotion Research, Curtin University
Enrollment
417
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 31, 2014
End Date
December 30, 2015
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
WA Centre for Health Promotion Research, Curtin University

Eligibility Criteria

Inclusion Criteria

  • The participants will be required to be 50\-65 years, low physical activity (less than 150 minutes of moderate physical activity per week), overweight/obesity (Body\-mass index (BMI) greater than or equal to 23 (Asian population), and includes any 3 of the following 5 risk factors:
  • Waist circumference (male greater than or equal to 90 cm, female greater than or equal to 80 cm for Asia Population); Raised triglycerides (greater than or equal to 1\.7 mmol/L or 150 mg/dL); Reduced HDL\-cholesterol (less than 1\.03 mmol/L or 40 mg/dL for males, less than 1\.29 mmol/L or 50 mg/dL for females); Raised blood pressure (systolic greater than or equal to 130 mmHg or diastolic greater than or equal to 85 mmHg); Raised plasma glucose (fasting plasma glucose greater than or equal to 6\.1 mmol/L).

Exclusion Criteria

  • Individuals who have received treatment for T2DM, CVD, hypertension, raised lipid profile, raised glucose, have taken part in any dietary and/or physical activity program within the past year, and be suspected to be diabetic (fasting plasma glucose greater than or equal to 7\.0mmol/L or greater than 126mg/dL) will be excluded

Outcomes

Primary Outcomes

Not specified

Similar Trials